(Q35219348)

7 August 2017

1 reference

title

The interleukin 2 receptor in the hypereosinophilic syndrome (English)

1 reference

7 August 2017

The Interleukin 2 Receptor in the Hypereosinophilic Syndrome (English)

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

hypereosinophilic syndrome

28 November 2023

main subject

1 reference

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

28 November 2023

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

28 November 2023

author name string

J. Plumas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1297479

10 September 2022

V. Gruart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1297479

10 September 2022

M. Capron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1297479

10 September 2022

A. Capron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1297479

10 September 2022

L. Prin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1297479

10 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1297479

10 September 2022

publication date

1 December 1992

1 reference

full work available at URL

7 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428199209051027

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

28 November 2023

1 reference

7 August 2017

volume

8

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

449-457

1 reference

The hypereosinophilic syndrome: clinical features, laboratory findings and treatment

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

B-cell lymphoma associated with eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Mechanism of eosinophilia. II. Role of the lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Recombinant human interleukin 5 is a selective activator of human eosinophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

T cell growth factor receptors. Quantitation, specificity, and biological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 2 receptor gene expression in normal human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Molecular cloning of cDNA encoding human interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Cloning, sequence and expression of human interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Structure of the human interleukin-2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

A new cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 2 regulates its own receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Demonstration of two distinct forms of released low-affinity type interleukin 2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Molecular cloning of a cDNA encoding the human interleukin 4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

The soluble interleukin-2 receptor: biology, function, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Eosinophilia associated with adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

HTLV-I and malignant hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Clinical effects and toxicity of interleukin-2 in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Human eosinophils express functional interleukin 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

The appearance of hypodense eosinophils during interleukin-2 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209051027

Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease

28 November 2023

4

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis

28 November 2023

5

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Evolution to eosinophilic leukemia with a t(5:11) translocation in a patient with idiopathic hypereosinophilic syndrome

28 November 2023

8

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

A case of the hypereosinophilic syndrome complicated by malignant lymphoma

28 November 2023

11

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases

28 November 2023

12

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Eosinophilia associated with a composite lymphoma

28 November 2023

13

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Hypereosinophilic syndrome preceding T cell lymphoblastic lymphoma

28 November 2023

15

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia

28 November 2023

19

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production

28 November 2023

34

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Interleukin 5 activity in sera from patients with eosinophilia.

28 November 2023

37

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family

28 November 2023

54

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Interleukin 5 up-regulates high-affinity interleukin 2 receptor expression by human resting peripheral T cells: a comparison with the effect of interleukin 4 on B cells

28 November 2023

63

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Interleukin-4 downregulates the p70 chain of the IL-2 receptor on peripheral blood mononuclear cells

28 November 2023

67

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features

28 November 2023

80

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Therapy of the hypereosinophilic syndrome

28 November 2023

86

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Alfa-interferon in a case of hypereosinophilic syndrome

28 November 2023

87

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Interferon-alpha for the hypereosinophilic syndrome

28 November 2023

88

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study

28 November 2023

102

1 reference

https://api.crossref.org/works/10.3109/10428199209051027

28 November 2023

Identifiers

1 reference

7 August 2017

1 reference